{"entity":{"type":"insider","cik":"0001363683","url":"/insider/0001363683","json_url":"/insider/0001363683.json","name":"Greenleaf Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":10,"first":"2016-11-30","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Greenleaf Peter","source":"filing","n_filings":10,"first_seen":"2016-11-30","last_seen":"2026-07-07"}],"transactions":[{"id":5806816,"accession":"0001919246-26-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001919246-26-000100","line_url":"/filing/0001919246-26-000100","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Pelthos Therapeutics Inc.","issuer_ticker":"PTHS","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":797.0,"shares_display":"797","price_per_share":26.131687954830614,"price_display":"26.13","price_state":"stated","total_value":20826.9553,"total_display":"20,826.96","total_whole":"20,827","shares_owned_after":23969.0,"shares_owned_after_display":"23,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-07","scope":"insider","n_lines":2},{"id":5759736,"accession":"0001919246-26-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001919246-26-000052","line_url":"/filing/0001919246-26-000052","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Pelthos Therapeutics Inc.","issuer_ticker":"PTHS","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":797.0,"shares_display":"797","price_per_share":20.91542007528231,"price_display":"20.92","price_state":"stated","total_value":16669.5898,"total_display":"16,669.59","total_whole":"16,670","shares_owned_after":25058.0,"shares_owned_after_display":"25,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider","n_lines":2},{"id":4046338,"accession":"0001600620-25-000024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001600620-25-000024","line_url":"/filing/0001600620-25-000024#line-4","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164947.0,"shares_display":"164,947","price_per_share":7.92,"price_display":"7.92","price_state":"stated","total_value":1306380.24,"total_display":"1,306,380.24","total_whole":"1,306,380","shares_owned_after":1788945.0,"shares_owned_after_display":"1,788,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4046337,"accession":"0001600620-25-000024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001600620-25-000024","line_url":"/filing/0001600620-25-000024#line-3","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195593.0,"shares_display":"195,593","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1564744.0,"total_display":"1,564,744.00","total_whole":"1,564,744","shares_owned_after":1953892.0,"shares_owned_after_display":"1,953,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":3095160,"accession":"0001600620-24-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000038","line_url":"/filing/0001600620-24-000038#line-1","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126981.0,"shares_display":"126,981","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":711093.6,"total_display":"711,093.60","total_whole":"711,094","shares_owned_after":1522114.0,"shares_owned_after_display":"1,522,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":9292954,"accession":"0001600620-24-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000013","line_url":"/filing/0001600620-24-000013#line-1","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33047.0,"shares_display":"33,047","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":290152.66,"total_display":"290,152.66","total_whole":"290,153","shares_owned_after":982671.0,"shares_owned_after_display":"982,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2024-02-22","scope":"insider"},{"id":8211728,"accession":"0001628280-23-006526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-006526","line_url":"/filing/0001628280-23-006526#line-2","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32750.0,"shares_display":"32,750","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":292785.0,"total_display":"292,785.00","total_whole":"292,785","shares_owned_after":982968.0,"shares_owned_after_display":"982,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6792094,"accession":"0001628280-22-005123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-22-005123","line_url":"/filing/0001628280-22-005123#line-2","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9068.0,"shares_display":"9,068","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":108906.68,"total_display":"108,906.68","total_whole":"108,907","shares_owned_after":32967.0,"shares_owned_after_display":"32,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":4489925,"accession":"0001628280-21-010022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-010022","line_url":"/filing/0001628280-21-010022","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5125.0,"shares_display":"5,125","price_per_share":10.71045268292683,"price_display":"10.71","price_state":"stated","total_value":54891.07,"total_display":"54,891.07","total_whole":"54,891","shares_owned_after":13453.0,"shares_owned_after_display":"13,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider","n_lines":2},{"id":6078632,"accession":"0001578563-18-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-18-000012","line_url":"/filing/0001578563-18-000012#line-1","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":49750.0,"total_display":"49,750.00","total_whole":"49,750","shares_owned_after":412500.0,"shares_owned_after_display":"412,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-21","scope":"insider"},{"id":2090545,"accession":"0001171843-16-013441","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001171843-16-013441","line_url":"/filing/0001171843-16-013441#line-4","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, Class A","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82459.0,"shares_display":"82,459","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":1381188.25,"total_display":"1,381,188.25","total_whole":"1,381,188","shares_owned_after":2513.0,"shares_owned_after_display":"2,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-30","scope":"insider"},{"id":2090542,"accession":"0001171843-16-013441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-16-013441","line_url":"/filing/0001171843-16-013441#line-2","is_derivative":false,"issuer_cik":"0001363683","issuer_name":"Sucampo Pharmaceuticals, Inc.","issuer_ticker":"SCMP","issuer_name_source":null,"issuer_url":"/issuer/0001363683","owner_cik":"0001363683","owner_name":"Greenleaf Peter","owner_display_name":"Greenleaf Peter","owner_url":"/insider/0001363683","role":"Officer (CEO)","role_mark":"O","role_mark_label":"Officer (CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, Class A","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117541.0,"shares_display":"117,541","price_per_share":16.91,"price_display":"16.91","price_state":"stated","total_value":1987618.31,"total_display":"1,987,618.31","total_whole":"1,987,618","shares_owned_after":2513.0,"shares_owned_after_display":"2,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-28","filed_date":"2016-11-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001919246","name":"Pelthos Therapeutics Inc.","url":"/issuer/0001919246","role":"Director","n_filings":2,"first_seen":"2026-04-06","last_seen":"2026-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2021-05-12","last_seen":"2025-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Cerecor Inc.","url":"/issuer/0001534120","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2018-05-21","last_seen":"2018-05-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001365216","name":"Sucampo Pharmaceuticals, Inc.","url":"/issuer/0001365216","role":"Officer (CEO)","n_filings":1,"first_seen":"2016-11-30","last_seen":"2016-11-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001363683","retrieved_at":"2026-08-27T17:01:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}